New combo therapy trial aims to extend lives in Tough-to-Treat cancer recurrence
Disease control
Recruiting now
This study is testing whether a two-step treatment—first repeat radiation with chemotherapy, followed by immunotherapy—works better than immunotherapy alone (with or without chemotherapy) for people whose head and neck cancer has returned locally. It will enroll about 214 adults …
Phase: PHASE3 • Sponsor: Universität des Saarlandes • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC